维普中文期刊产品整合服务
93篇 您的检索式:作者名="Pasanisi"
    题名 作者 年代 出处 被引量
1Hepatic steatosis in overweight/obese females: New screening method for those at risk显示文摘AIM: To identify which parameters could help to distinguish the 'metabolically benign obesity', which is not accompanied by insulin resistance (IR) and early atherosclerosis.METHODS: Eighty two of 124 overweight/obese females formed the study population, which was divided into two groups (52 and 30 subjects, respectively) with and without IR according to a HO meostatic Metabolic Assessment (HOMA) cut-off of 2, and were studied in a cross-sectional manner. The main outcome measures were waist circumference, serum uric acid, high-density lipoprotein-cholesterol and triglycerides, alanine amino-transferase, blood pressure and the two imaging para-meters, hepatic steatosis and longitudinal diameter of the spleen, which were measured in relation to the presence/absence of IR. RESULTS: A variable grade of visceral obesity was observed in all subjects with the exception of three.Obesity of a severe grade was represented more in the group of IR individuals (P = 0.01). Hepatic steatosis, revealed at ultrasound, was more pronounced in IR than in non-IR subjects (P = 0.005). The two groups also demonstrated a clear difference in longitudinal spleen diameter and blood pressure, with raised and signif icant values in the IR group. Metabolic syndrome was frequent in the IR group, and was not modified when adjusted for menopause (P = 0.001). At linear regression, the β values of waist circumference and body mass index predicting HOMA were 0.295, P = 0.007 and 0.41, P = 0.0001, respectively. Measures of spleen longitudinal diameter were well predicted by body mass index (BMI) values, β = 0.35, P = 0.01, and by HOMA, β = 0.41, P = 0.0001. Blood pressure was predicted by HOMA values, β = 0.39, P = 0.0001). HOMA and hepatic steatosis were highly associated (rho = 0.34, P = 0.002). Interestingly, IR patients were almost twice as likely to have hepatic steatosis as non-IR patients. Among the MS criteria, blood pressure was very accurate in identifying the presence of IR (AUROC for systolic blood pressure 0.66, cut-off 125 mm of Hg, sensibility 64%, specif icity 75%; AUROC for diastolic blood pressure 0.70, cut-off 85 mm of Hg, sensibility 54.5%, specif icity 75%). CONCLUSION: As health care costs are skyrocketing, reliable and mainly inexpensive tools are advisable to better defi ne subjects who really need to lose weight.Giovanni Tarantino Genoveffa Pizza Annamaria Colao Fabrizio Pasanisi Paolo Conca Patrizia Colicchio Carmine Finelli Franco Contaldo Carolina Di Somma Silvia Savastano 2009World Journal of Gastroenterology2009,15,45:4
2Obesity epidemics: simple or simplicistic answers? 显示文摘Contaldo F Pasanisi F 2005Clin Nutr2005,24,1:1
3Cochlear implantation and Cogan syndrome显示文摘Pasanisi E Vincenti V Bacciu A 2003Otology & Neurotology2003,24,:1
4Nutritional screening and early treatment of malnutrition in cancer patients 显示文摘Santarpia L Contaldo F Pasanisi F 2011J Cachexia Sarcopenia Muscle2011,2,:1
5Effect of different doses of metformin on serum testosterone and insulin in non-diabetic women with breast cancer:a randomized study显示文摘Campagnoli C Pasanisi P AbbàC 2012Clin Breast Cancer2012,12,3:1
6Reduced hemodynamic load and cardiac hypotrophy in patients with anorexia nervosa显示文摘 Chinali M Pasanisi F 2003Am J Clin Nutr2003,77,2:1
7Improved recognition of dysfunctioning myocardial segments by longitudinal strain rate versus velocity in patients with myocardial infarction显示文摘Mele D Pasanisi G Heimdal H 2004J Am Soc Echocardiogr2004,17,9:1
8Cochlear implantation in a human immunodeficiency virus-infected patient显示文摘Vincenti V Pasanisi E Bacciu A 2005Laryngoscope2005,115,6:1
9Serum testosterone levels and breast cancer recurrence显示文摘 PASANISI P BELLATI C 2005113(3):499-5022005,113,3:1
10Metabolic syndrome as a prognostic factor for breast cancer recurrences显示文摘 BERRINO F DE PETRIS M 2006Int J Cancer2006,119,1:1
11Appropriate or inappropriate left ventricular mass in the presence or absence of prognostically adverse left ventricular hypertrophy 显示文摘Mureddu GF Pasanisi F Palmieri V 2001J Hypertens2001,19,:1
12The diagnostic accuracy of pharmacological stress echocardiography for the assessment of coronary artery disease: a meta-analysis显示文摘Picano E Molinaro S Pasanisi E 2008Cardiovasc Ultrasound2008,6,:1
13Sacchetti high leptin/adiponectin ratio and serum triglycerides are associated with an ' at-risk' phenotype in young severely obese patients 显示文摘Giuseppe LF Pasanisi C Nardelli R 2011Obesity Silver Spring Md2011,19,7:1
14Left intraventricular myocardial deformation dyssynchrony identifies responders to cardiac resynchronization therapy in patients with heart failure 显示文摘Mele D Pasanisi G Capasso F 2006Eur Heart J2006,27,9:1
15Link of nonhemodynamic factors to hemodynamic determinants of left ventricular hypertrophy显示文摘De Simone G Pasanisi F Contaldo F 2001Hypertension2001,38,1:1
16Functional analysis of melanocortin-4-receptor mutants identified in severely obese subjects living in Southern Italy显示文摘Alfieri A Pasanisi F Salzano S 2010Gene2010,457,12:1
17Improved recognition of dysfunction myocardial segments by longitudinal strain rate versus velocity in patients with myocardial infarction 显示文摘Mele D Pasanisi G Heimdal A 2004J Am Soc Echocardiogr2004,17,4:1
18Effect of different doses of metformin on serum testosterone and insulin in non- diabetic women with breast cancer: a randomized study显示文摘Campagnoli C Pasanisi P Abbd C 2012Clin Breast Cancer2012,12,3:1
19Scutumplasty:costal cartilage versus bone pate显示文摘Bacciu S Pasanisi E Perez-Raffo G 1998Auris Nasus Larynx1998,25,2:1
20Nutritional screening and early treatment of malnutrition in cancer patients显示文摘Santarpia L Contaldo F Pasanisi F 2011J Cach Sarcop Muscl2011,2,1:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费